Challenge of mast cells with increasing amounts of antigen induces desensitization
- 1 September 1995
- journal article
- Published by Wiley in Clinical and Experimental Allergy
- Vol. 25 (9) , 896-902
- https://doi.org/10.1111/j.1365-2222.1995.tb00033.x
Abstract
In vivo rush desensitization is a procedure widely employed to quickly desensitize allergic patients by administering increasing doses of the offending antigen at short intervals. The mechanism(s) underlying this process and the possible role of mast cells in it have not been well delineated. To define an ex vivo model for rush desensitization utilizing the mast cell-fibroblast coculture system. Rat peritoneal mast cells were cultured on 3T3 fibroblasts and were preincubated with saturating or suboptimal concentrations of IgE anti-DNP antibodies. Mast cells were then repeatedly challenged at 30 min intervals, with increasing amounts (0.001-100 ng/mL) of the antigen DNP-HSA, in the presence of calcium ions. Parallel control cultures were stimulated only once by each antigen concentration. In another set of experiments, mast cells were repeatedly activated with increasing concentrations (0.1-1000 ng/mL) of compound 48/80. Supernatants and cell sonicates were assessed for histamine content and the percentage of histamine released was calculated. When saturating concentrations of IgE anti-DNP antibodies were used, mast cells challenged repeatedly with DNP-HSA did not release significant amounts of histamine up to an antigen concentration of 1 ng/mL. At this stage they were partially desensitized, releasing only 108.3 +/- 17.1 ng histamine/plate (7.9 +/- 0.8%). A marked desensitization was observed at optimal antigen concentration (100 ng/mL), where experimental mast cells released only 45.6 +/- 10.9 ng/plate, compared with 661.9 +/- 48.2 ng/plate in firstly challenged cultures. Desensitization was probably not due to mast cells histamine depletion, since the cells still contained large amounts of histamine (579.5 +/- 108.6 ng/plate) at the end of the procedure. A similar pattern of desensitization was observed when mast cells were preincubated with a suboptimal concentration of IgE antibodies. Activation of mast cells with increasing amounts of the IgE-independent secretagogue, compound 48/80, did not cause desensitization since at each concentration both repetitively challenged and control cultures released similar amounts of histamine. Furthermore, challenge of antigen-desensitized mast cells with compound 48/80 caused the release of 75.9 +/- 4.9% histamine comparable to the percentage of histamine released from controls (79.5 +/- 6.7). Repeated exposure of mast cells to gradually increasing amounts of antigen induces their refractoriness. This observation would suggest a role for mast cells in rush desensitization procedure in vivo. Our coculture system may serve as a useful model for studying this process.Keywords
This publication has 19 references indexed in Scilit:
- Clinical and immunologic studies of rapid venom immunotherapy in Hymenoptera-sensitive patientsJournal of Allergy and Clinical Immunology, 1989
- In vitro regeneration of activated rat peritoneal mast cells cocultured with 3T3 fibroblastsCellular Immunology, 1989
- Basophil histamine release remains unaffected by clinical desensitization to penicillinJournal of Allergy and Clinical Immunology, 1988
- Itravenous desensitization to beta-lactam antibioticsJournal of Allergy and Clinical Immunology, 1987
- Activation of Basophils and Mast Cells for Mediator ReleaseInternational Archives of Allergy and Immunology, 1987
- Penicillin Allergy and Desensitization in Serious Infections during PregnancyNew England Journal of Medicine, 1985
- Agents that Release Histamine from Mast CellsAnnual Review of Pharmacology and Toxicology, 1983
- Antigen-specific desensitization of patients allergic to penicillinJournal of Allergy and Clinical Immunology, 1982
- Insulin therapy in patients with systemic insulin allergyArchives of internal medicine (1960), 1975